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Molecular characterization of HIV-1 
Nef and ACOT8 interaction: insights 
from in silico structural predictions 
and in vitro functional assays
Michela Serena1, Alejandro Giorgetti2, Mirko Busato2, Francesca Gasparini1,2, Erica Diani1, 
Maria Grazia Romanelli1 & Donato Zipeto1
HIV-1 Nef interacts with several cellular proteins, among which the human peroxisomal thioesterase 
8 (ACOT8). This interaction may be involved in the endocytosis regulation of membrane proteins and 
might modulate lipid composition in membrane rafts. Nef regions involved in the interaction have 
been experimentally characterized, whereas structural details of the ACOT8 protein are unknown. 
The lack of structural information hampers the comprehension of the functional consequences of the 
complex formation during HIV-1 infection. We modelled, through in silico predictions, the ACOT8 
structure and we observed a high charge complementarity between Nef and ACOT8 surfaces, which 
allowed the identification of the ACOT8 putative contact points involved in the interaction. The 
predictions were validated by in vitro assays through the development of ACOT8 deletion mutants. 
Coimmunoprecipitation and immunofluorescence analyses showed that ACOT8 Arg45-Phe55 and 
Arg86-Pro93 regions are involved in Nef association. In addition, K91S mutation abrogated the 
interaction with Nef, indicating that Lys91 plays a key role in the interaction. Finally, when associated 
with ACOT8, Nef may be preserved from degradation. These findings improve the comprehension 
of the association between HIV-1 Nef and ACOT8, helping elucidating the biological effect of their 
interaction.
Nef is an HIV-1 accessory protein involved in several mechanisms modulating the virus infectious cycle1. Some 
long-term non-progressor patients have been found to carry HIV-1 mutants with deletions in nef or with a 
high frequency of defective nef alleles2–4. Several functions of Nef have been documented in tissue cultures: Nef 
enhances viral infectivity and replication in PBMC5,6, alters the state of T-cell activation and macrophage signal 
transduction pathways7–9, inhibits the immunoglobulin class switching10, reduces the cell surface expression of 
the CD4 receptor11, whose internalization and degradation is essential to increase the infectivity of the released 
HIV-1 viral particles12,13. Finally, Nef downregulates the cell surface expression of MHC-I molecules to escape the 
host immune response14–18 and associates with several components of the endocytic pathways19.
Nef is described as a raft-associated protein, through its N-terminal myristoylation, which is necessary for its 
anchorage to the cell membrane20,21. Myristoylated Nef can adopt several quaternary structures as monomers, 
dimers and trimers and it may associate with other proteins22,23. However, myristoylation of Nef alone is insuffi-
cient for lipid binding, suggesting that more complex interactions are necessary to allow its migration and binding 
to the membrane20. An additional Nef-interacting protein is the human thioesterase 8 (ACOT8)24,25, which is a 
peroxisomal enzyme involved in lipid metabolism. The human ACOT8 gene is located on chromosome 20q13.12 
and codes for a 319 aa residues protein of approximately 35 kDa24,26. Due to the serine-lysine-leucine (SKL) per-
oxisomal targeting signal, it is localized in peroxisomes24,26,27. It has been shown that murine ACOT8 is inhibited 
by Coenzyme A (CoASH)28, differently from the Type-I ACOTs. Thus, the sensitivity to CoASH and the very 
broad substrate specificity suggest a role for this enzyme in regulating the intra-peroxisomal acyl-CoA/CoASH 
level in order to optimize the fatty acids flux through the β -oxidation system. In contrast to the peroxisomal 
Type-I ACOTs, ACOT8 shows a broad tissue expression range both in mice and humans25,28. However, the role of 
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this enzyme in lipid metabolism is not clear. Although ACOT8 structure has not been solved by crystallography, 
Li and co-workers29 solved the three-dimensional structure of the Escherichia coli thioesterase II by X-ray crystal-
lography. The latter shares about 41% of aminoacidic sequence identity with ACOT8. While E. coli thioesterase II 
is a tetramer, the human thioesterase 8 is present both in dimeric and tetrameric forms30. Yeast two-hybrid studies 
have shown that HIV-1 Nef directly interacts with ACOT824,25. HIV-1 Nef-LAI residues from Asp108 to Trp124 
(in particular Asp108, Leu112, Phe121, Pro122, Asp123) have been identified as essential for ACOT8 interaction30,31. 
It has been demonstrated that expression of ACOT8 promotes the relocalization of Nef to peroxisomes in 3T3 
cells30. Nef/ACOT8 colocalization in peroxisomes requires the C-terminal peroxisomal targeting sequence of 
ACOT8. Several hypotheses were proposed to explain why HIV-1 Nef associates with ACOT8. Since it has been 
reported that the preferred substrates of ACOT8 are myristoyl-CoA and palmitoyl-CoA24, ACOT8 activity could 
be involved in the control of lipid modifications of proteins, which are important for their membrane anchoring 
and receptor internalization31. Previous reports showed that palmitoylation could influence the rate of endocy-
tosis of molecules at the plasma membrane32–34. Thus, ACOT8 could act on the acylation of these proteins by 
regulating the intracellular level of acyl-CoA. In addition, lipid rafts are preferential sites for HIV-1 viral particles 
budding35 and it has been reported that hydrolysis of long chain fatty acyl-CoA is required for correct budding 
of Coat Protein Complex I (COP-I) coated vesicles36, whose β -COP subunit is a Nef interacting target37. In the 
absence of acyl-CoA, buds accumulate and coated vesicles fail to pinch off. Since ACOT8 hydrolyses a broad 
range of acyl-CoA and Nef may enhance its enzymatic activity in a dose dependent manner25, it is likely that the 
Nef-mediated ACOT8 recruitment may be involved in intracellular transport pathways modification.
So far, research studies have been focused on determining the Nef regions involved in the interaction with 
ACOT8. In this work, through in silico predictions, we modelled the human ACOT8 structure starting from the 
E. coli thioesterase to perform a docking analysis between HIV-1 Nef and ACOT8. The ACOT8 amino acids most 
likely involved in the interaction with Nef were predicted and several ACOT8 deletion mutants were developed 
and analysed for their interacting properties and ability to target Nef in the peroxisomes. Through coimmuno-
precipitation and immunofluorescence assays, we observed that ACOT8 Lys91 is essential for Nef binding. Finally, 
expression analysis of Nef and ACOT8 suggests that the Nef/ACOT8 association may have a role in reducing Nef 
degradation.
Results
Computational ACOT8 model. For the modelling procedure, the pairwise sequence alignment between 
ACOT8 and the E. coli thioesterase (Fig. 1a) was extracted from the Hidden Markov profiles generated using the 
HHpred program38. A bundle of models comprising 100 decoys was generated and filtered using the Modeller 
scoring function. All the obtained three-dimensional models of ACOT8 did not deviate from currently availa-
ble experimental geometries, indicating that both the secondary structures elements (12-stranded antiparallel 
β -sheets) and the typical tertiary fold (the double hot dog)29 were conserved in the model. The monomer-mono-
mer interface between the two subunits of the dimer was totally buried in the protein, involving the central frag-
ments of the six central β -sheets from the two monomers to form several stabilizing interactions, all conserved in 
the template (Fig. 1b). The contact surface was structurally similar to that of E. coli enzyme, i.e. 1980 and 2142 Å2 
per monomer for the target and the template, respectively.
Initial model of Nef/ACOT8 interaction. The electrostatic potential on Nef/ACOT8 surfaces (Fig. 2a,b) 
showed a high electrostatic complementarity, i.e. a negatively charged surface on Nef-LAI and a positively 
charged one on ACOT8. In particular, the latter corresponded to one of the ACOT8 high probability interaction 
regions identified on the molecule through the CPORT (Consensus Prediction of interface Residues in Transient 
complexes) web server tool, which calculates a prediction score for each residue of the query protein, in this case 
Figure 1. ACOT8 homology modelling. (a) Sequence alignment between Acyl-coenzyme A thioesterase 8 
(ACOT8_HUMAN) and E. coli thioesterase II (1C8U). ▲ indicates aromatic and aliphatic residues (Tyr47, Pro50, 
Pro90, Leu92) of ACOT8, which are replaced by non-hydrophobic residues in E. coli isoenzyme (Glu, Gly, Ser and 
Lys respectively). The residues are coloured according to their physico-chemical properties (HKR in cyan, DE in 
red, STNQ in maroon, AVLIM in pink, FYW in blue, PG in orange and C in green). (b) The modelled ACOT8 
dimer (chain A in blue and chain B in brownish). The homology model of ACOT8 was built based on the X-ray 
structure of the E. coli thioesterase. The two enzymes share about 41% of sequence identity.
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ACOT8 (Fig. 2c). The residues with a high prediction score are supposed to be involved in the interaction with 
Nef. These computational predictions on ACOT8 and the available experimental data on Nef 30,31, were combined 
together to guide the docking procedure using HADDOCK, to gain a better insight into the Nef/ACOT8 interac-
tion (Fig. 3). HADDOCK results pointed principally to a most populated cluster (111/200 decoys) of structures 
that contained the best scoring models. Specifically, the root-mean-square-deviation (RMSD) of the backbone 
atoms from the overall lowest-energy structure was 0.64 ± 0.40 Å. A total of five clusters were obtained, with the 
second most populated comprising just 53/200 decoys, and while the HADDOCK score was about − 222.6 for 
the first cluster, in the second it was − 96.7. Thus, the representative structure of the most populated cluster was 
analysed in order to extract information on the residues present in the Nef/ACOT8 interface. In this cluster, salt 
bridges were found between Lys52 of ACOT8 and Asp108 and Asp111 of Nef-LAI, but also between Lys91 of ACOT8 
and Asp123 of Nef. In addition to this salt bridge networks, 11 hydrogen-bond interactions occurred between Nef 
and ACOT8 and hydrophobic contacts were detected between three residues of Nef, i.e. Leu112, Phe121 and Pro122 
and three residues of ACOT8, i.e. Tyr47, Pro50 and Pro90.
Figure 2. Electrostatic potentials and CPORT prediction. Electrostatic potentials on the ACOT8 (a) and 
the Nef (b) surfaces. The Nef/ACOT8 electrostatic complementarity can be vividly visualized by the plots of 
the electrostatic potential, calculated solving the Poison-Boltzmann equation51. The contact surfaces of Nef 
and ACOT8 are clearly complementary: while the surface of Nef is highly negative (red), the contact surface of 
ACOT8 is highly positively charged (blue). (c) CPORT prediction: the ACOT8 residues with a high prediction 
score are likely supposed to be involved in the interaction with Nef. In the figure, red/orange colour means a 
high prediction score, whereas blue colour means a low prediction score.
Figure 3. Docking model. Nef (yellow) and ACOT8 (brownish) docking model. The ACOT8 Arg45-Phe55 and 
Arg86-Pro93 regions are highlighted in green and in cyan respectively. For both proteins, N- and C-terminals are 
coloured in orange and magenta respectively. Nef amino acids, starting from Asp123, involved in proteasome 
degradation are highlighted in red.
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Development of ACOT8 deletion mutants and their expression. Taking into account the hypothet-
ical contact points identified from the Nef/ACOT8 complex model, two ACOT8 point mutants were produced in 
correspondence of Lys52 (p∆ PAK) and Lys91 (p∆ PK). A non-peroxisomal ACOT8 mutant was also obtained by 
point mutation of the peroxisomal target signal, from SKL317–319 to SKR317–319. To extend the comprehension of 
the Nef/ACOT8 association, the ∆ PAK (Arg45-Phe55), ∆ PK (Arg86-Pro93) and ∆ PAK-∆ PK (both Arg45-Phe55 and 
Arg86-Pro93) mutants were prepared, too.
Coimmunoprecipitation assay between Nef and ACOT8 mutants. To assess the association 
between Nef and the ACOT8 point mutants, a coimmunoprecipitation assay was performed. CHO cells were 
cotransfected with plasmids encoding for ACOT8 mutants (p∆ PAK and p∆ PK) and HA-tagged Nef. The com-
plexes were immunoprecipitated with an anti-HA antibody. Western blot analysis of the immunoprecipitated 
lysates (Fig. 4a) confirmed that no interaction occurred between Nef from HIV-1 SF2 strain (Nef-SF2) and 
ACOT8, while a strong association was detected after coexpression of Nef-LAI with ACOT8, confirming pre-
vious data30. Analysing the association between Nef-LAI and ACOT8 mutants, we observed that the pΔPAK 
mutant was present in immunocomplexes with Nef-LAI, suggesting that the ACOT8 Lys52 may not be involved 
in the interaction. On the contrary, the pΔPK mutant was not found associated with Nef-LAI, indicating that the 
ACOT8 Lys91 may play a key role in the complex formation. Western blot analysis of the whole protein extracts 
(input) showed that Nef-LAI expression was increased in the presence of ACOT8, as well as the p∆ PAK mutant. 
This effect was not observed either for Nef-SF2 or for the non-interacting p∆ PK mutant.
Analysis of the influence of ACOT8 on Nef expression. To investigate the effect of ACOT8 on Nef 
expression levels, CHO cells were cotransfected with Nef-LAI and increasing amounts of ACOT8 (Fig. 4b). 
Western blot analysis indicated that the amount of Nef-LAI detected was directly correlated to ACOT8 expres-
sion: the more ACOT8 is expressed, the more Nef-LAI is detected. On the contrary, when CHO cell were cotrans-
fected with the non interacting Nef-SF2 and increasing amounts of ACOT8 (Fig. 4c), Nef-SF2 is similarly express. 
When Nef-LAI was cotransfected with increasing amounts of either p∆ PAK or p∆ PK ACOT8 mutants, the 
Nef-LAI expression levels were related to the p∆ PAK expression (Fig. 4d) while, in the presence of the p∆ PK 
mutant (Fig. 4e), unable to interact with Nef-LAI, such correlation was not observed.
Nef and ACOT8 mutants colocalization. To better explore the interaction between Nef and ACOT8, 
CHO cells were cotransfected with Nef-LAI and ACOT8 mutants. Through immunofluorescence it was assessed 
their association (Fig. 5), as well as the Nef localization in peroxisomes (Fig. 6). Immunostaining of Nef-LAI 
revealed a cytoplasmic distribution, with a prevalent localization at the perinuclear region (Fig. 5a), while ACOT8 
showed a clear peroxisomal localization (Fig. 5b). When the two proteins were coexpressed, Nef-LAI was com-
pletely targeted to peroxisomal regions, where the association with ACOT8 occurs (Fig. 5c). In the presence of 
the non-peroxisomal ACOT8-SKR mutant, the association with Nef-LAI was maintained, but it was not localized 
in peroxisomes (Fig. 5d).
Nef-LAI and pΔPAK colocalization signal did not differ from that observed in the Nef-LAI/ACOT8 cotrans-
fected cells (Fig. 5e). On the contrary, the Nef-LAI association was partially lost with the pΔPK mutant (Fig. 5f).
The ΔPAK mutation resulted in a loss of association with Nef-LAI (Fig. 5g), which was abrogated in the pres-
ence of the ΔPK mutant (Fig. 5h); as a consequence, Nef-LAI remained prevalently localized at the perinuclear 
region. The double ΔPAK-ΔPK mutation completely abolished Nef/ACOT8 interaction (Fig. 5i).
Peroxisomal staining indicated that Nef-LAI was not localized in the peroxisomes (Fig. 6a), but when cotrans-
fected with ACOT8 it was relocated in the peroxisomes (Fig. 6b). The non-peroxisomal mutant (ACOT8-SKR) 
lost the ability to target Nef-LAI in these organelles (Fig. 6c). Transfection of the pΔPAK mutant still induced the 
Nef-LAI peroxisomal localization (Fig. 6d), while in the presence of the pΔPK mutant no labelling of Nef-LAI in 
the peroxisomes was detected (Fig. 6e). The ΔPAK mutation resulted in a reduced Nef-LAI peroxisomal targeting 
(Fig. 6f), which appeared to be more severe in the presence of the ΔPK mutant (Fig. 6g). The ΔPAK-ΔPK mutant 
completely abrogated the colocalization between Nef-LAI and peroxisomes (Fig. 6h). Overall, the results obtained 
analysing both the Nef/ACOT8 and the Nef/peroxisomes colocalization were comparable.
Comparison between Nef-LAI and Nef-SF2. Nef-LAI and Nef-SF2 differ by 30 aminoacidic residues. 
Analysing the sequence alignment (Fig. 7a), and in particular the 108–124 Nef-LAI region, it was observed that 
Asp108 is swapped in glutamic acid in SF2 (residue 112 in SF2 homologous). As reported by Cohen and collabo-
rators, this mutation is responsible for the lack of interaction with ACOT830. From the structural point of view, 
in Nef-SF2 the longer side-chain of the glutamic acid might form an intramolecular salt bridge interaction with 
the closest Arg109 (following the Nef-SF2 numbering system) (Fig. 7b). Consequently, the residue would not be 
available to interact with ACOT8, weakening a putative salt-bridge network.
It has been also proved that the N-terminal region of Nef-LAI could be involved in the interaction or in the 
stabilization of the Nef/ACOT8 complex30. Unfortunately, this region was not solved for the Nef-LAI crystal 
structure, and therefore it was not possible to include it in the model.
Knowledge-based Nef/ACOT8 complex model. To model the Nef/ACOT8 complex, in order to 
explain all the available experimental data, a new virtual protein-protein docking between the structural model 
of Nef-LAI and ACOT8 was carried out. The docking procedure was guided with our in vitro experimental data, 
resulting in three different clusters of decoys. The best score model of the most populated cluster (165/200 decoys) 
was analysed. In particular, several pairs of amino acids were identified showing a high electrostatic complemen-
tarity. Indeed, again, while ACOT8 shows a positively charged interaction surface, formed principally by Arg43, 
Arg45, His46, Lys52, Arg53, Arg86 and Lys91, Nef negatively charged surface is formed by Asp108, Asp111, Asp123. In 
particular, salt bridges were found between ACOT8 Lys91 and Nef Asp108 and Asp111, and also between ACOT8 
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Arg53 and Nef Asp108, and finally between the ACOT8 Arg43 and Nef Asp123. In this Nef/ACOT8 model, while res-
idues in the Arg45-Phe55 loop (deleted in the ∆ PAK mutant) seem to be involved in complex stabilization, Lys52 is 
not involved in the interaction, as observed by in vitro experiments. Several intermolecular hydrophobic contacts 
were also formed between three residues of Nef, i.e. Leu112, Phe121 and Pro122 and five residues of ACOT8 i.e. Tyr47, 
Pro50, Pro90, Leu92 and Pro93, allowing a further stabilization of the complex (Fig. 8).
This hypothesis could be supported by the observation that some of these hydrophobic amino acids, i.e. Tyr47, 
Pro50, Pro90, Leu92, are lacking in the E. coli thioesterase and this may be the reason why the interaction with Nef 
does not take place, as previously observed by Cohen and colleagues30. In fact, in the E. coli thioesterase, these 
residues are substituted by non-hydrophobic residues (Glu, Gly, Ser and Lys respectively), completely changing 
the physico-chemical properties of the interaction surface (Fig. 1).
Figure 4. Coimmunoprecipitation assay between Nef and ACOT8 mutants. (a) CHO cells were 
cotransfected with Nef-LAI and ACOT8 mutants as indicated in the panel. Nef-SF2 was used as negative 
control. Whole cell extracts were quantified and analysed with anti-HA or anti-ACOT8 antibodies, as 
indicated. α /β tubulin expression was used as a control. The Nef/ACOT8 mutants association was analysed by 
immunoprecipitation of the complexes with the anti-HA antibody. Western blot analysis of immunoprecipitated 
lysates, performed with the anti-ACOT8 antibody, shows that only the wild type ACOT8 and the p∆ PAK 
mutant interact with Nef-LAI. CHO cells were cotransfected with either Nef-LAI (b) or Nef-SF2 (c) and 
increasing amounts of ACOT8. Similarly, they were cotransfected with increasing amount of either the p∆ PAK 
(d) or the p∆ PK mutant (e) and Nef-LAI. ACOT8 and Nef expression was analysed by Western blot. α /β 
tubulin expression was used as control. Nef and ACOT8 expression was calculated from the same membrane 
by densitometry analysis using the ImageJ software and normalized to α /β tubulin. Percentages relative either 
to the minimum amount of transfected ACOT8 construct, or to the Nef transfection, are indicated under each 
western blot image.
www.nature.com/scientificreports/
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Figure 5. Colocalization assay between Nef and ACOT8 mutants. CHO cells cotransfected with Nef-LAI  
(a), ACOT8 (b), Nef-LAI and ACOT8 (c), Nef-LAI and ACOT8-SKR (d), Nef-LAI and p∆ PAK (e), Nef-LAI 
and p∆ PK (f), Nef-LAI and ∆ PAK (g), Nef-LAI and ∆ PK (h), Nef-LAI and ∆ PAK-∆ PK (i). Nef was detected 
using an anti-HA antibody (green signal); ACOT8 was detected using an anti-ACOT8 antibody (red signal). 
Merge images represent the images of the localization of Nef and ACOT8 overlaid. Overlap of Nef and ACOT8 
results in a yellow colour. On the right side, the RGB profile plotted along the line drawn in the merged image is 
shown. Merge and single-channel images come from a single z-plane.
www.nature.com/scientificreports/
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Figure 6. Nef localization in peroxisomes in the presence of ACOT8 mutants. CHO cells transfected with 
Nef-LAI (a), Nef-LAI and ACOT8 (b), Nef-LAI and ACOT8-SKR (c), Nef-LAI and p∆ PAK (d), Nef-LAI and 
p∆ PK (e), Nef-LAI and ∆ PAK (f), Nef-LAI and ∆ PK (g), Nef-LAI and ∆ PAK-∆ PK (h). Nef was detected 
using an anti-HA antibody (green signal); peroxisomes were detected using an anti-peroxisomes antibody (red 
signal). Merge images represent the images of the localization of Nef and peroxisomes overlaid. Overlap of Nef 
and peroxisomes results in a yellow colour. On the right side, the RGB profile plotted along the line drawn in the 
merged image is shown. Merge and single-channel images come from a single z-plane.
www.nature.com/scientificreports/
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Discussion
The association between HIV-1 Nef and the peroxisomal human thioesterase 8 (ACOT8) has been described24,25 
and the Nef regions responsible for the association with ACOT8 have been characterized30,31. Current literature 
indicates that HIV-1 Nef is the only known viral protein interacting with ACOT8, but the structural properties 
of the ACOT8 regions interacting with Nef have never been characterized. Thus, for many years the role of the 
Nef/ACOT8 association remained unclear. Previous data reported that the interaction between Nef and ACOT8 
results in a relocalization of Nef from its cytoplasmic distribution to the peroxisomes30. Recently Gondim et al.39 
demonstrated that among the different known Nef interacting proteins, ACOT8 shows the strongest association. 
In the same study, it was reported that ACOT8 is not involved in CD4 downregulation, as previously hypothe-
sized25,32. The study also showed that the Nef membrane localization is not strictly required for the interaction 
with ACOT8, suggesting that their association might occur early during HIV-1 infection. In addition, the authors 
observe that the Δ17–26 Nef mutant, which is known to be unable to downregulate MHC-I molecules40, does 
not interact with ACOT8, suggesting that ACOT8 might be involved in Nef-mediated MHC-I downregulation.
Our study aims to identify, for the first time, the critical ACOT8 residues involved in the interaction with Nef, 
an important step toward the elucidation of the biological role of their interaction. Bioinformatic tools allowed 
to predict the ACOT8 regions most likely involved in the interaction with Nef and to plan the construction of 
several mutants. It was then possible to generate a model able to explain all the experimentally identified residues 
involved in Nef/ACOT8 interaction30,31. Two point mutants were developed by deletion of Lys52 (pΔPAK mutant) 
and Lys91 (pΔPK mutant). A non-peroxisomal ACOT8 mutant was obtained by mutation of the peroxisomal 
target signal (PTS) 1, from SKL to SKR. Coimmunoprecipitation analysis confirmed that ACOT8 associated with 
Nef-LAI, but not with the Nef variant from HIV-1-SF230. The pΔPAK mutant showed interaction with Nef-LAI 
Figure 7. Sequence alignment between Nef-SF2 and Nef-LAI. (a) ▲ indicates some residues differences 
between the two alleles in the N-terminal region and in Glu112 corresponding to Asp108 in Nef-LAI. The residues 
are coloured according to their physico-chemical properties (HKR in cyan, DE in red, STNQ in maroon, 
AVLIM in pink, FYW in blue, PG in orange and C in green). (b) Superimposition of Nef-LAI structure (in 
cyan) and Nef-SF2 structure (in brownish) shows that, while Nef-SF2 Glu112 might interact with the Nef-SF2 
Arg109 due its longer side-chain, Nef-LAI Asp108 (shorter side-chain) could not be involved in an intramolecular 
salt bridge with Nef-LAI Arg105, remaining free to interact with ACOT8.
Figure 8. Detail of the knowledge guided Nef/ACOT8 complex . Residues involved in the Nef/ACOT8 
interaction, characterized in this work for ACOT8 and by Liu31 and Cohen30 for Nef, are shown. The colour 
code is the same as in Fig. 3.
www.nature.com/scientificreports/
9Scientific RepoRts | 6:22319 | DOI: 10.1038/srep22319
similarly to wild type ACOT8, while the pΔPK mutant did not show any association. These findings indicate 
that the ACOT8 Lys52 (pΔPAK) is not fundamental for the binding, but the Lys91 may play a role in the Nef/
ACOT8 association. In particular, western blot analysis indicated that the Nef-LAI detection was strictly cor-
related to ACOT8: the more ACOT8 is expressed, the more Nef-LAI is detected. On the contrary, no effect was 
observed when ACOT8 was cotransfected with Nef-SF2, suggesting that the ACOT8 association to Nef could 
have a stabilizing role for the Nef expression. This finding was further confirmed when Nef-LAI was cotrans-
fected with ACOT8 mutants: increasing amount of the p∆ PAK correlated with increasing expression of Nef-LAI, 
while no evident correlation was observed in the presence of the p∆ PK mutant, which resulted unable to interact 
with Nef-LAI. This data, beyond confirming that Lys91 is important for interacting with Nef, point out that the 
Nef/ACOT8 association might have a functional role during HIV-1 infection, preventing the Nef degradation. 
Interestingly, it has been reported that, in the first step of HIV-1 replication, proteasome can interact with Nef41. 
Indeed, it has been demonstrated that the Nef 123 to 152 region (Nef123–152) is one of the immunogenic domains 
involved in proteasomal digestion and that the region comprising amino acids 128 to 135 is one of the principal 
cleavage products42. The Nef123–152 segment is highly conserved among different HIV-1 Nef variants43 (as indi-
cated in Fig. 7a) but, since this region overlaps with the Nef/ACOT8 interaction surface, we hypothesize that 
when Nef binds ACOT8, the proteasome could not interact, probably due to steric hindrance.
To better explore the Nef/ACOT8 interaction, ACOT8 mutants harbouring wider deletions, either in the 
Arg45-Phe55 region (ΔPAK mutant), or in the Arg86-Pro93 region (ΔPK mutant), were prepared. A double mutant 
harbouring both ΔPAK and ΔPK deletions was also obtained (ΔPAK-ΔPK mutant). The interaction between 
ACOT8 mutants and Nef was further assessed by immunofluorescence. As expected, cotransfection of Nef-LAI 
and ACOT8 resulted in a strong association in the peroxisomes, according to previous data30. In the presence of 
the non-peroxisomal ACOT8 mutant, Nef-LAI remained associated with ACOT8-SKR, but their localization 
was widespread, highlighting the importance of the ACOT8 PTS1 sequence for the Nef peroxisomal localization. 
Analysing the effect of ACOT8 mutants, it was observed that in the presence of the pΔPAK mutant, the associ-
ation with Nef-LAI was maintained and an ACOT8-like Nef peroxisomal localization was observed. The pΔPK 
mutant showed a reduced association with Nef-LAI and the Nef peroxisomal targeting was lost. The same effect 
was observed in the presence of the ΔPAK mutant. The ΔPK mutation abrogated the interaction with Nef-LAI, 
which showed a prevalent perinuclear localization. In the presence of the ΔPAK-ΔPK mutant the interaction with 
Nef-LAI was completely lost and no peroxisomal colocalization was detected.
Our data indicate that the ACOT8 Lys91 may play a key role, since its single mutation to Ser91 is sufficient 
to abrogate the association with Nef. In particular, the positive charge of Lys91 may have a fundamental role in 
maintaining the charge complementarity observed in the docking model, which appears to be crucial for the 
association with Nef.
However, the observation that both Arg45-Phe55 and Arg86-Pro93 may be determinant for Nef association sug-
gests that other residues may contribute to the Nef binding, meaning that more than a single interaction occurs. 
This is in agreement with previous speculations indicating that a cooperative effect might subsist between sepa-
rated points of interaction30.
All the experimental data were finally summarized in a Nef/ACOT8 model (Fig. 8), where the ACOT8 Lys91 
resulted to interact with Asp108 and Asp111 of Nef-LAI, while the ACOT8 Lys52, as experimentally observed, did 
not appear to be involved in the interaction. Moreover, in this model, the ACOT8 Arg53 showed electrostatic 
interactions with Nef-LAI Asp108, validating the observation that the ∆ PAK mutation (Arg45-Phe55) abrogated 
the interaction with Nef. Our predictions were further supported by the interesting observation that in Nef-SF2, 
not interacting with ACOT8, the residue corresponding to Nef-LAI Asp108, which resulted to be necessary for 
the formation of salt bridges with ACOT8 Lys91, is swapped in glutamic acid. Currently, the biological function 
of the association between Nef and ACOT8 has not yet been elucidated. Several hypotheses have been proposed, 
suggesting that ACOT8 may be involved in the control of lipid modifications of proteins, which are important for 
membrane anchoring of proteins and receptor internalization. In addition, through the intracellular regulation 
of acyl-CoA, ACOT8 may influence Nef myristoylation. The Nef/ACOT8 association may also ensure an effi-
cient HIV-1 virions budding, modifying the composition of membrane lipids. Interestingly, it has been reported 
that Nef plays a significant role in pathogenesis of lipid-related metabolic complications of HIV-1 infection44. 
However, whether Nef has any need to be localized to peroxisomes is not clear. It has been hypothesized that 
when Nef is present in excess over ACOT8, such as in HIV-1-infected cells, the Nef/ACOT8 complex might colo-
calize predominantly outside the peroxisomes30.
Our data support the hypothesis that the Nef association to ACOT8 may improve the Nef stability, proba-
bly preventing its proteasome-mediated degradation. In conclusion, our results indicate that in the absence of 
an experimentally determined structure, as in the case of ACOT8, computational models, within their limita-
tions, are often helpful for generating testable hypotheses and giving insight into existing experimental data45–47. 
This experimental/computational combined study, through the identification of the ACOT8 regions most likely 
involved in the interaction with Nef (Arg45-Phe55 and Lys91), elucidates the association between HIV-1 Nef and 
human ACOT8. Our data open the way for further studies aimed at improving the comprehension of the biologi-
cal role of their interaction. ACOT8 mutants originated and characterized in this study, may help to elucidate the 
role of the interaction in ACOT8-knock out cell lines.
Since any ACOT8 deficiency has been correlated to lipid metabolism impairment, due to the human thioester-
ase redundancy, the development of ACOT8 inhibitors could be exploited as a novel strategy to interfere with 
several Nef cellular functions as well as with the HIV-1 infective life cycle.
Methods
ACOT8 homology modelling. To obtain the ACOT8 model, protein sequences of all members of the 
ACOT8 family were retrieved from the Uniprot database. A multiple sequence alignment was built using the 
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PROMALS program48,49. The sequences were used for the definition of a Hidden Markov Model (HMM) profile 
of the ACOT8 family using the HHsearch program49. All alignments were displayed using the ESPript 3.0 web-
server50. The multiple sequence alignment obtained was used as reference for the structural prediction of ACOT8 
by homology modelling based on the crystal structure of the E. coli thioesterase [PDB: 1C8U] and the dimeric 
functional configuration was generated and relaxed using the Modeller9v3 program46.
Prediction Nef/ACOT8 interface and Dockings: CPORT-HADDOCK. To model the Nef/ACOT8 
interaction, the crystal structure of Nef-LAI [PDB: 1AVV] was used. Since the residues from 148–178 are missing, 
this region was integrated using the structure of Nef-LW123 [PDB: 2NEF]. In both structures the experimental 
binding region was conserved and the inserted loop was far from it. The Nef/ACOT8 electrostatic potentials were 
calculated using the APBS program51. The CPORT (Consensus Prediction Of interface Residues in Transient 
complex) bioinformatic tool, a consensus method combining six interface web servers (WHISHY, PIER, ProMate, 
cons-PPISP, SPIDER and PINUP), was used as interface prediction program52. The Nef/ACOT8 docking model 
was then performed using the HADDOCK (High Ambiguity Driven biomolecular DOCKing) version 2.1 
program53,54, based on the previously described bioinformatics predictions. These latter were introduced as 
Ambiguous Interaction Restraints (AIRs) to drive the docking process. The docking was performed with default 
parameters using the web-server version of HADDOCK. All calculations were performed with CNS1.255. 
Non-bonded interactions were calculated with the OPLS force field using a cut-off of 8.5 Å56. The electrostatic 
potential was calculated using a shift function, while a switching function (between 6.5 and 8.5 Å) was used to 
define the Van der Waals potential. The ambiguous interaction restraints to drive the docking were defined con-
sidering as Nef active residues Asp108, Leu112, Phe121, Pro122 and Asp123 30,31, whereas for ACOT8 the active residues 
were Arg43, Arg45, His46, Lys52, Arg53, Arg86 and Lys91. They were chosen considering both the charge complemen-
tarity between Nef and ACOT8, and the CPORT prediction. Passive residues were defined automatically via the 
web server as those surrounding the active ones. Docking results were visualized using the CHIMERA program57.
Knowledge-based Nef/ACOT8 model. To drive the second docking, the amino acids considered as active 
for Nef were the same as the first docking and no passive amino acids were defined. For ACOT8, only Lys91 was 
chosen as active residue and Arg86, Ala87, Gly88, Asp89, Pro90, Leu92 and Pro93 were defined as passive residues.
Cell lines. CHO (Chinese Hamster Ovary) cells were obtained from the American Type Culture Collection 
(ATCC). They were grown at 37 °C in a humidified atmosphere with 5% CO2 and maintained in Dulbecco’s 
Modified Eagle’s Medium supplemented with 10% FBS, 2mM L-Glutamine, 100 U Penicillin/ml and 100 U 
Streptomycin/ml. Mycoplasma testing was routinely performed. CHO cells were chosen since endoge-
nous ACOT8 differs from human ACOT8 in the N-terminal region, which is the epitope recognized by the 
anti-ACOT8 antibody used.
Vectors. HIV-1-LAI Nef (Nef-LAI) and HIV-1-SF2 Nef (Nef-SF2) plasmids were provided by M. Pizzato 
(CIBIO, Trento, Italy). Both sequences harbour a C-terminal HA-tag58. The ACOT8 plasmid was provided by 
S. Benichou (Institut Cochin de Genetique Moleculaire, France)24.
ACOT8 mutants. The p∆ PAK mutant has a point deletion of Lys52; the p∆ PK has a missense mutation 
from Lys91 to Ser91. The ∆ PAK was obtained by deleting Arg45-Phe55, the ∆ PK by deleting Arg86-Pro93 and the 
∆ PAK-∆ PK double mutant by introducing both deletions. Each mutant was obtained from the wild type ACOT8 
gene by PCR amplification of the fragment upstream and downstream each deletion. Primer pairs were devel-
oped to join the two fragments with specific restriction sites. The p∆ PAK and ∆ PAK mutants harboured the KasI 
restriction site both in the reverse primer of the upstream fragment (5′ -GGCGCCTACCCAGTAATGCCTTCC-3′ 
and 5′ -GGCGCCTCCTCTGAAGAGATCCTC-3′ respectively) and in the forward primer of the downstream frag-
ment (5′ -GGCGCCAGGCTGTTTGGTGGTCAG-3′ and 5′ -GGCGCCGGTGGTCAGATCGTGGGC-3′ respec-
tively). The p∆ PK and ∆ PK mutants harboured the BmtI site both in the reverse primer of the upstream fragment 
(5′ -GCTAGCGTCCCCTGCCCGAACAAA-3′ and 5′ -GCTAGCAACAAAGTAGCAGTGCAG-3′ , respec-
tively) and in the forward primer of the downstream fragment (5′ -GCTAGCCTGCCAGTACTGTACCAA-3′ 
and 5′ -GCTAGCGTACTGTACCAAGTGGAG-3′ , respectively). The ∆ PAK-∆ PK double mutant was obtained 
from the ∆ PAK by PCR amplification of the fragments upstream and downstream the ∆ PK deletion. To insert 
the full constructs in pcDNA3, the forward primer of the upstream fragments harboured the HindIII site 
(5′ -CTATAGGGAGACCCAAGCTT-3′ ) and the reverse primer of the downstream fragments harboured the 
ApaI site (5′ -TTGGGCCCTCTGGCTACAGCTTGC-3′ ). Each fragment pair was joined through KasI or BmtI 
sites and the full fragment was cloned in pcDNA3 through HindIII and ApaI sites. The ACOT8-SKR mutant, 
missing the peroxisomal localization signal, was developed by PCR inserting a SKL to SKR mutation. A reverse 
primer (5′ -GGGCCCTCTGGCTACCGCTTGC-3′ ) harbouring the mutation was used. The fragment was cloned 
in pcDNA3 through HindIII and ApaI restriction sites. Each construct was verified by direct sequencing.
Antibodies. The anti-HA mouse antibody (Covance) was used to detect HA-tagged Nef, while the 
anti-ACOT8 N-19 goat antibody (Santa Cruz Biotechnologies) was used to detect the expression of ACOT8 
mutants. Tubulin was detected using the anti α /β -tubulin antibody (Cell Signaling); the anti-PMP-70 antibody 
from guinea pig59 was used for peroxisomal staining. HRP-conjugated anti-mouse (Promega), HRP conjugated 
rabbit anti-sheep (Thermo Scientific) and HRP-conjugated goat anti-rabbit (PerkinElmer) antibodies were used 
for western blot assay. For immunofluorescence, the Alexa Fluor 488 conjugated goat anti-mouse (Cell Signaling), 
the Alexa Fluor 594 conjugated donkey anti-goat (Life Technologies) and the Alexa Fluor 555 conjugated goat 
anti-guinea pig (Life Technologies) antibodies were used.
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Transfections. Cells were transfected with the TransIT-LT1 transfection reagent (Mirus Bio), following man-
ufacturer’s instructions.
Coimmunoprecipitation assay. Cells (2.8 × 105) were seeded on 60 mm dishes, cotransfected the follow-
ing day with both 2.5 μg of either Nef-LAI or Nef-SF2 expressing plasmid and 4 μg of the ACOT8 constructs. Total 
DNA was compensated to the same amount with the pcDNA3 empty vector. Coimmunoprecipitation was per-
formed 48 hours post-transfection as previously described60. Briefly, cells were harvested and washed in ice cold 
PBS 1X, resuspended in 240 μl of non-denaturing lysis buffer (10 mM Tris–HCl, pH 7.5, 5 mM EDTA, 150 mM 
NaCl, 1% Triton X-100) and incubated for 10 minutes on ice. Lysates were sonicated twice for 5 seconds and fro-
zen at − 20 °C for 1 hour. Cellular debris was removed by centrifugation. Proteins obtained were quantified and 
incubated overnight at 4 °C with 2 μg of anti-HA antibody, and immunocomplexes were linked to Dynabeads® 
protein G (Life Technologies) at 4 °C for 30 minutes. Beads were washed with PBS 1X and resuspended in elu-
tion buffer containing NuPAGE loading buffer (Life Technologies) and 0.25 mM dithiothreitol for western blot 
analysis.
Western blot analysis of Nef/ACOT8 coexpression. CHO cells (2.8 × 105) were seeded on 60 mm 
dishes and cotransfected the following day with both 2.5 μg of either Nef-LAI or Nef-SF2 expressing plasmid and 
increasing amounts of the ACOT8 construct, as well as increasing amount of the p∆ PAK and p∆ PK constructs 
(2 μg, 3 μg, 4 μg). Total DNA was compensated to the same amount with the pcDNA3 empty vector. Forty-eight 
hours after transfection, cells were lysed in RIPA buffer and proteins were quantified. Equivalent amounts of 
proteins (15 μg) were treated with 3% β -mercaptoethanol and separated by SDS-PAGE on a 10% acrylamide 
gel. Nef and ACOT8 were detected using either the anti-ACOT8 antibody or the anti-HA antibody, followed by 
HRP-conjugated anti-mouse or anti-sheep antibody incubation, respectively. As a control, α /β -tubulin was used. 
The signal was developed using the ECL AdvanceTM Western Blotting Detection Kit (Amersham), through the 
AutoChemi System UVP (BioImaging System). Densitometry analysis was performed using the ImageJ software. 
Relative Nef and ACOT8 band intensity was normalized to α /β -tubulin from the same membrane.
Immunofluorescence assay. Cells (2 × 104) were seeded on 8-well CultureSlide (BD Falcon), cotransfected 
the following day with both 250 ng of Nef-LAI expressing plasmid and 400 ng of each ACOT8 construct; 48 hours 
post-transfection, cells were fixed with 2% paraformaldehyde and permeabilized with 0.3% Triton X-100. 
Colocalization analysis of Nef-LAI with ACOT8 mutants was performed with the anti-HA antibody, followed by 
the Alexa Fluor 488 conjugated goat anti-mouse antibody, and with the N-19 antibody, followed by Alexa Fluor 
594 conjugated donkey anti-goat antibody incubation. For peroxisomes labelling, cells were stained with the 
anti-PMP-70 antibody, followed by Alexa Fluor 555 conjugated goat anti-guinea pig antibody. Control samples, in 
which the primary antibody for Nef, ACOT8 or PMP-70 was left out, were included in each experiment to exclude 
any antibody cross-reactivity. Nuclei were labelled with 1 μg/ml Hoechst in PBS. Images were captured using a 
confocal laser-scanning fluorescence microscope Leica TCS SP5 with a HCX PL APO objective, 1.4 numerical 
aperture, 63 × magnification and analysed with LAS AF software (Leica). RGB profile was calculated using the 
ImageJ software, with the RGB profiler plugin.
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